Abstract
Rabies is an acute, progressive encephalitis of mammals and has the highest case fatality proportion of any conventional infectious disease. This disease is an ancient, reemerging global zoonosis, caused by highly neurotropic viruses in the family Rhabdoviridae, genus Lyssavirus [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Franka R, Rupprecht CE. Treatment of rabies in the 21st century: curing the incurable? Future Microbiol. 2011;6:1135–40.
Wunner WH. Rabies virus. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 23–68.
Plotkin SA, Koprowski H, Rupprecht CE. Rabies vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. New York: Springer; 2008. p. 687–714.
CDC. Compendium of animal rabies prevention and control. MMWR Morb Mortal Wkly Rep. 2011;60(RR-6):1–17.
CDC. Use of reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies. MMWR Morb Mortal Wkly Rep. 2010;59(No. RR-2):1–12.
Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis. 2002;2:327–43.
Dietzschold B, Schnell M, Koprowski H. Pathogenesis of rabies. Curr Top Microbiol Immunol. 2005;292:45–56.
Hemachudha T. Human rabies: clinical aspects, pathogenesis, and potential therapy. In: Rupprecht CE, Dietzschold B, Koprowski H, editors. Lyssaviruses. New York: Springer; 1994. p. 121–43.
Fekadu M. Latency and aborted rabies. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton: CRC Press; 1991. p. 191–200.
Fekadu M, Summer JW, Shaddock JH, et al. Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. J Virol. 1992;66:2601–4.
Rosner F. Rabies in the Talmud. Med Hist. 1974;18:198–200.
Steele JH, Fernandez PJ. History of rabies and global aspects. In: Baer GM, editor. The natural history of rabies. Boca Raton: CRC Press; 1991. p. 1–24.
Baer GM. Rabies – an historical perspective. Infect Agents Dis. 1994;3:168–80.
Wilkinson L. The development of the virus concept as reflected in corpora of studies on individual pathogens. 4. Rabies – two millennia of ideas and conjecture on the aetiology of a virus disease. Med Hist. 1977;21:15–31.
Rupprecht CE, Dietzschold B, Wunner WH, et al. Antigenic relationships of lyssaviruses. In: Baer GM, editor. The natural history of rabies. Boca Raton: CRC Press; 1991. p. 69–100.
Smith JS, Orciari LA, Yager PA, et al. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J Infect Dis. 1992;166:296–307.
Smith JS, Fishbein DB, Rupprecht CE, et al. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med. 1991;324:205–11.
Smith JS, Seidel HD. Rabies: a new look at an old disease. Prog Med Virol. 1993;40:82–8106.
Bourhy H, Kissi B, Tordo N. Molecular diversity of the Lyssavirus genus. Virology. 1993;194:70–81.
King AA, Meredith CD, Thomson GR. The biology of southern African lyssavirus variants. Curr Top Microbiol Immunol. 1994;187:267–95.
Wiktor TJ. Historical aspects of rabies treatment. In: Koprowski H, Plotkin S, editors. World’s Debt to Pasteur. New York: Liss; 1985. p. 141–51.
Celis E, Rupprecht CE, Plotkin SA. New and improved vaccines against rabies. In: Woodrow GC, Levine MM, editors. New generation vaccines. New York: Marcel Dekker; 1990. p. 419–38.
Thraenhart O, Marcus I, Kreuzfelder E. Current and future immunoprophylaxis against human rabies: reduction of treatment failures and errors. Curr Top Microbiol Immunol. 1994;187:173–94.
Briggs DJ, Schwenke JR. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine. 1992;10:125–9.
Wiktor TJ, Sokol F, Kuwert E, et al. Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc Soc Exp Biol Med. 1975;131:799–805.
Goldwasser RA, Kissling RE. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc Soc Exp Biol Med. 1958;98:219–23.
Wandeler AI, Matter HC, Kappeler A, et al. The ecology of dogs and canine rabies: a selective review. Rev Sci Tech. 1993;12:51–71.
Dyer J, Wallace R, Orciari LA, et al. Rabies surveillance in the United States during 2012. J Am Vet Med Assoc. 2013;243(6):805–15.
Blanton JD, Palmer D, Dyer J, et al. Rabies surveillance in the United States during 2010. J Am Vet Med Assoc. 2011;239(6):773–83.
Christian KA, Blanton JD, Auslander M, et al. Epidemiology of rabies post-exposure prophylaxis – United States of America, 2006–2008. Vaccine. 2009;27:7156–61.
Smith JS. Rabies serology. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton: CRC Press; 1991. p. 235–54.
Ma X, Niezgoda M, Blanton JD, et al. Evaluation of a new serological technique for detecting rabies virus antibodies following vaccination. Vaccine. 2012;30(36):5358–62.
Hill RE, Beran GW, Clark WR. Demonstration of rabies virus-specific antibody in the sera of free-ranging Iowa raccoons (Procyon lotor). J Wildl Dis. 1992;28:377–85.
Roess AA, Rea N, Lederman E, et al. National surveillance for human and pet contact with oral rabies vaccine baits, 2001-2009. J Am Vet Med Assoc. 2012;240:163–8.
Nadin-Davis SA, Velez J, Malaga C, et al. A molecular epidemiological study of rabies in Puerto Rico. Virus Res. 2008;131:8–15.
Linhart SB, Creekmore TE, Corn JL, et al. Evaluation of baits for oral rabies vaccination of mongooses: pilot field trials in Antigua, West Indies. J Wildl Dis. 1993;29:290–4.
Organization WH. WHO expert committee on rabies—8th report. World Health Organ Tech Rep Ser. 1992;824:1–84.
Rudd RJ, Trimarchi CV. Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis. J Clin Microbiol. 1989;27:2522–8.
Coertse J, Nel LH, Sabeta CT, et al. A case study of rabies diagnosis from formalin-fixed brain material. J S Afr Vet Assoc. 2011;82:250–3.
Lembo T, Niezgoda M, Velasco-Villa A, et al. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis. 2006;12(2):310–3.
Niezgoda M, Rupprecht CE. Standard operating procedure for the direct rapid immunohistochemistry test for the detection of rabies virus antigen. National Laboratory Training Network Course. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2006. p. 1–16.
Brito MG, Chamone TL, da Silva FJ, et al. Antemortem diagnosis of human rabies in a veterinarian infected when handling a herbivore in Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo. 2011;53:39–44.
Smith JS. Rabies virus. In: Murray PR et al., editors. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press; 1995. p. 997–1003.
Kamolvarin N, Tirawatnpong T, Rattanasiwamoke R, et al. Diagnosis of rabies by polymerase chain reaction with nested primers. J Infect Dis. 1993;167(1):207–10.
McColl KA, Gould AR, Selleck PW, et al. Polymerase chain reaction and other laboratory techniques in the diagnosis of long incubation rabies in Australia. Aust Vet J. 1993;70:84–9.
Sacramento D, Bourhy H, Tordo N. PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol Cell Probes. 1991;5:229–40.
Bourhy H, Kissi B, Lafon M, et al. Antigenic and molecular characterization of bat rabies virus in Europe. J Clin Microbiol. 1992;30:2419–26.
Feiden W, Kaiser E, Gerhard L, et al. Immunohistochemical staining of rabies virus antigen with monoclonal and polyclonal antibodies in paraffin tissue sections. Zentralbl Veterinarmed B. 1988;35(4):247–55.
Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis. 1987;9:511–8.
Fekadu M, Endeshaw T, Alemu W, et al. Possible human-to-human transmission of rabies in Ethiopia. Ethiop Med J. 1996;34(2):123–7.
Organization WH. Two rabies cases following corneal transplantation. Wkly Epidemiol Rec. 1994;69:330.
Vetter JM, Frisch L, Drosten C, et al. Survival after transplantation of corneas from a rabies-infected donor. Cornea. 2011;30:241–4.
Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med. 2005;352:1103–11.
Wandeler AI, Nadin-Davis SA, Tinline RR, et al. Rabies epidemiology: some ecological and evolutionary perspectives. Curr Top Microbiol Immunol. 1994;187:297–324.
Artois M, Aubert M, Blancou J. Behavioral ecology of the transmission of rabies. Ann Rech Vet. 1991;22:163–72.
CDC. Raccoon rabies epizootic—United States, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:269–73.
Rupprecht CE, Smith JS. Raccoon rabies: the emergence of an epizootic in a densely populated area. Semin Virol. 1994;5:155–64.
Mallory LB. Campaign against rabies in Modoc and Lassen Counties. Calif State Board Health Mon Bull. 1915;11:273–7.
Clark KA, Neill SU, Smith JS, et al. Epizootic canine rabies transmitted by coyotes in south Texas. J Am Vet Med Assoc. 1994;204:536–40.
Sidwa TJ, Wilson PJ, Moore GM, et al. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995-2003. J Am Vet Med Assoc. 2005;227:785–92.
Velasco-Villa A, Reeder SA, Orciari LA, et al. Enzootic rabies elimination from dogs and reemergence in wild terrestrial carnivores, United States. Emerg Infect Dis. 2008;14(12):1849–54.
Charlton KM. The pathogenesis of rabies and other lyssaviral infections: recent studies. Curr Top Microbiol Immunol. 1994;187:95–119.
Smith GL. Virus strategies for evasion of the host response to infection. Trends Microbiol. 1994;2:81–8.
Gosztonyi G, Dietzschold B, Kao M, et al. Rabies and borna disease. A comparative pathogenetic study of two neurovirulent agents. Lab Invest. 1993;68:285–95.
Schneider LG. Spread of virus within the central nervous system. In: Baer GM, editor. The natural history of rabies. New York: Academic; 1975. p. 199–216.
Shankar V, Dietzschold B, Koprowski H. Direct entry of rabies virus into the central nervous system without prior local replication. J Virol. 1991;65:2736–8.
Stöhr K, Meslin FM. Progress and setbacks in the oral immunisation of foxes against rabies in Europe. Vet Rec. 1996;139:32–5.
Bourhy H, Dacheux L, Strady C, et al. Rabies in Europe in 2005. Euro Surveill. 2005;10:213–6.
Carvalho-Costa FA, Tedesqui VL, de Jesus Nascimento Monteiro M, et al. Outbreaks of attacks by hematophagous bats in isolated riverine communities in the Brazilian Amazon: a challenge to rabies control. Zoonoses Public Health. 2012;59:272–7.
Schneider MC, Santos-Burgoa C, Aron J, et al. Potential force of infection of human rabies transmitted by vampire bats in the Amazonian region of Brazil. Am J Trop Med Hyg. 1996;55:680–4.
Rupprecht CE, Turmelle AS, Kuzmin IV. A perspective on lyssavirus emergence and perpetuation. Curr Opin Virol. 2011;1(6):662–70.
Kuzmin IV, Novella IS, Dietzgen RG, et al. The rhabdoviruses: biodiversity, phylogenetics, and evolution. Infect Genet Evol. 2009;9(4):541–53.
Banyard AC, Hayman D, Johnson N, et al. Bats and lyssaviruses. Adv Virus Res. 2011;79:239–89.
Kuzmin IV, Turmelle AS, Agwanda B, et al. Commerson’s leaf-nosed bat (Hipposideros commersoni) is the likely reservoir of Shimoni bat virus. Vector Borne Zoonotic Dis. 2011;11:1465–70.
Kuzmin IV, Mayer AE, Niezgoda M, et al. Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res. 2010;149:197–210.
Childs JE, Colby L, Krebs JW, et al. Surveillance and spatiotemporal associations of rabies in rodents and lagomorphs in the United States, 1985-1994. J Wildl Dis. 1997;33:20–7.
Nettles VF, Shaddock JH, Sikes RK, et al. Rabies in translocated raccoons. Am J Public Health. 1979;69:601–2.
CDC. First human death associated with raccoon rabies—Virginia, 2003. Morb Mortal Wkly Rep. 2009;52(45):1102–3.
Blanton JD, Dyer J, McBrayer J, et al. Rabies surveillance in the United States during 2011. J Am Vet Med Assoc. 2012;241:712–22.
Fogelman V, Fischman HR, Horman JT, et al. Epidemiologic and clinical characteristics of rabies in cats. J Am Vet Med Assoc. 1993;202:1829–33.
Brett W. Petersen and Charles E. Rupprecht (2011). Human Rabies Epidemiology and Diagnosis, Non-Flavivirus Encephalitis, Dr. Sergey Tkachev (Ed.), ISBN: 978-953-307-720-8, InTech, DOI: 10.5772/21708. Available from: http://www.intechopen.com/books/non-flavivirus-encephalitis/human-rabies-epidemiology-and-diagnosis.
Dietzschold B, Rupprecht CE, Tollis M, et al. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect Dis. 1988;10 Suppl 4:785–98.
Davlin SL, Vonville HM. Canine rabies vaccination and domestic dog population characteristics in the developing world: a systematic review. Vaccine. 2012;30:3492–502.
CDC. Human rabies – Minnesota, 2007. Morb Mortal Wkly Rep. 2008;57(17):460–2.
CDC. Human rabies prevention—United States, 2008. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(No. RR-3):1–28.
Vora NM, Basavaraju SV, Feldman KA, et al. Racoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398–407.
A large-scale, rapid public health response to rabies in an organ recipient and the previously undiagnosed organ donor. Zoonoses Public Health. 2014 Mar 27. doi: 10.1111/zph.12105.
Constantine DG. Rabies transmission by nonbite route. Public Health Rep. 1962;77:287–9.
CDC. Rabies in a laboratory worker—New York. Morb Mortal Wkly Rep. 1977;26:183–4.
Winkler WG, Fashinell TR, Leffingwell L, et al. Airborne rabies transmission in a laboratory worker. JAMA. 1973;226:1219–21.
Johnson N, Phillpotts R, Fooks AR. Airborne transmission of lyssaviruses. J Med Microbiol. 2006;55:785–90.
Charlton KM, Webster WA, Casey GA. Skunk rabies. In: Baer GM, editor. Natural history of rabies. 2nd ed. Boca Raton: CRC Press; 1991. p. 307–24.
Fu ZF, Weihe E, Zheng YM, et al. Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J Virol. 1993;67:6674–81.
Balachandran A, Charlton K. Experimental rabies infection of non-nervous tissues in skunks (Mephitis mephitis) and foxes (Vulpes vulpes). Vet Pathol. 1994;31:93–9102.
Jackson AC. Pathogenesis. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 341–72.
Hanlon CA, Niezgoda M, Rupprecht CE. Rabies in terrestrial animals. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 201–46.
Hill RE, Beran GW. Experimental inoculation of raccoons (Procyon lotor) with rabies virus of skunk origin. J Wildl Dis. 1992;28:51–6.
Hill RE, Smith KE, Beran GW, et al. Further studies on the susceptibility of raccoons (Procyon lotor) to a rabies virus of skunk origin and comparative susceptibility of striped skunks (Mephitis mephitis). J Wildl Dis. 1993;29:475–7.
Baer GM, Shaddock JH, Quirion R, et al. Rabies susceptibility and acetylcholine receptor. Lancet. 1990;335:664–5.
Rupprecht CE, Dietzschold B. Perspectives on rabies virus pathogenesis. Lab Invest. 1987;57:603–6.
Rupprecht CE, Hamir AN, Johnston DH, et al. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev Infect Dis. 1988;10 Suppl 4:803–9.
Dietzschold B, Wang HH, Rupprecht CE, et al. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci U S A. 1987;84:9165–9.
Dietzschold B, Tollis M, Rupprecht CE, et al. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. J Infect Dis. 1987;156:815–22.
Tollis M, Dietzschold B, Volia CB, et al. Immunization of monkeys with rabies ribonucleoprotein (RNP) confers protective immunity against rabies. Vaccine. 1991;9:134–6.
Aubert MF, Masson E, Artois M, et al. Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France. Curr Top Microbiol Immunol. 1994;187:219–43.
Brouchier B, Kieny MP, Costy F, et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature. 1991;354:520–2.
Wandeler AI. Oral immunization of wildlife. In: Baer GM, editor. The natural history of rabies. Boca Raton: CRC Press; 1991. p. 485–503.
Organization WH. Oral immunization of foxes in Europe in 1994. Wkly Epidemiol Rec. 1995;70:89–91.
Slate D, Algeo TP, Nelson KM, et al. Oral rabies vaccination in North America: opportunities, complexities, and challenges. PLoS Negl Trop Dis. 2009;3(12):e549. doi: 10.1371/journal.pntd.0000549.
Held JR, Tierkel ES, Steele JH. Rabies in man and animals in the United States, 1946-65. Public Health Rep. 1967;82:1009–18.
Dreesen DW. Animal vaccines. In: Jackson AC, Wunner WH, editors. Rabies. 2nd ed. London: Elsevier; 2007. p. 517–30.
Lembo T, Attlan M, Bourhy H, et al. Renewed global partnerships and redesigned roadmaps for rabies prevention and control. Vet Med Int. 2011;2011:923149.
Prevention PfR. Blueprint for rabies prevention and control. August 2010. Available at: http://www.rabiesblueprint.com/.
Kieny MP, Lathe R, Drillien R, et al. Expression of the rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984;312:163–6.
Wiktor TJ, MacFarlan RI, Reagan KJ, et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A. 1984;81:7194–8.
Wiktor TJ, MacFarlan RI, Dietzschold B, et al. Immunogenic properties of vaccinia recombinant virus expressing the rabies glycoprotein. Ann Inst Past/Virol. 1985;136E:405–11.
Rupprecht CE, Wiktor TJ, Johnston DH, et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc Natl Acad Sci U S A. 1986;83:7947–50.
Blancou J, Kieny MP, Lathe R, et al. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature. 1986;332:373–5.
Pastoret PP, Brouchier B, Languet B, et al. First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet Rec. 1988;123:481–3.
Rupprecht CE, Hanlon CA, Hamir AN, et al. Oral wildlife rabies vaccination: development of a recombinant virus vaccine. In: McCabe RE, editor. Transactions of the 57th North American Wildlife and Natural Resources Conference—1992. Washington, DC: Wildlife Management Institute; 1992. p. 439–52.
Tolson ND, Charlton K, Stewart RB, et al. Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res. 1987;52:363–6.
Tolson ND, Charlton K, Casey GA, et al. Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein. Arch Virol. 1990;102:297–301.
Thomas I, Brochier B, Languet B, et al. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. J Gen Virol. 1990;71(Pt 1):37–42.
Hanlon CA, Hayes DE, Hamir AN, et al. Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): site selection, target species characteristics, and placebo baiting trials. J Wildl Dis. 1989;25:555–67.
Hanlon CA, Buchanan JR, Nelson E, et al. A vaccinia-vectored rabies vaccine field trial: ante- and post-mortem biomarkers. Rev Sci Tech. 1993;12:99–9107.
Rupprecht CE, Charlton KM, Artois M, et al. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis. 1990;26:99–9102.
Van Regenmortel MH, Fauquet CM, Bishop DHL, et al. Virus taxonomy: classification and nomenclature of viruses. Seventh report of the international committee on taxonomy of viruses. San Diego: Academic; 2000. p. 227–37.
Yarosh OK, Wandeler AI, Graham FL, et al. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine. 1996;14:1257–64.
Knowles MK, Nadin-Davis SA, Sheen M, et al. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species. Vaccine. 2009;27:6619–26.
Knowles MK, Roberts D, Craig S, et al. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB). Vaccine. 2009;27(20):2662–8.
Aubert M. Control of rabies in foxes: what are the appropriate measures? Vet Rec. 1994;134:55–9.
Cho HC, Lawson KF. Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human). Can J Vet Res. 1989;53:434–7.
Wilson PJ, Oertli EH, Hunt PR, et al. Evaluation of a postexposure rabies prophylaxis protocol for domestic animals in Texas: 2000-2009. J Am Vet Med Assoc. 2010;237:1395–401.
Blancou J, Baltazar RS, Molli I, et al. Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine. Vaccine. 1991;9:432–7.
Fishbein DB, Bernard KW, Miller KD, et al. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am J Trop Med Hyg. 1986;35:663–70.
CDC. Human rabies—Kenya. Morb Mortal Wkly Rep. 1983;32:494–5.
Services DoHaH. Public Health Service Centers for Disease Control and Prevention. National Institutes of Health HHS Publication No. (CDC) 21-1112. Revised Dec 2009.
Xiang ZW, Spitalink S, Tran M, et al. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 1994;199:132–40.
Schumacher CL, Dietzschold B, Ertl HC, et al. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest. 1989;84:971–5.
Rupprecht CE, Shankar V, Hanlon CA, et al. Beyond Pasteur to 2001: future trends in lyssavirus research? In: Rupprecht CE, Dietzschold B, Koprowski H, editors. Lyssaviruses. New York: Springer; 1994. p. 325–40.
Lafon M, Lafage M. Antiviral activity of monoclonal antibodies specific for the internal proteins N and NS of rabies virus. J Gen Virol. 1987;68(Pt 12):3113–23.
Meslin FX, Fishbein DB, Matter HC. Rationale and prospects for rabies elimination in developing countries. Curr Top Microbiol Immunol. 1994;187:1–26.
Rupprecht CE, Dietzschold B, Campbell JB, et al. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores. J Wildl Dis. 1992;28:629–35.
Wilde H, Chomchey P, Punyaratabandhu P, et al. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin. Bull World Health Organ. 1989;67:731–6.
Wilde H, Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am J Trop Med Hyg. 1990;42:175–8.
Quiambao BP, Dy-Tioco HZ, Dizon RM, et al. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines. Vaccine. 2009;27:7162–6.
Wilde H, Chomchey P, Prakongsri S, et al. Adverse effects of equine rabies immune globulin. Vaccine. 1989;7:10–1.
Dietzschold B, Kao M, Zheng YM, et al. Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system. Proc Natl Acad Sci U S A. 1992;89:7252–6.
Willoughby RE, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508–14.
Mrak RE, Young L. Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology. J Neuropathol Exp Neurol. 1994;53:1–10.
Jackson AC. Therapy of human rabies. In: Jackson AC, editor. Advances in virus research. London: Elsevier; 2012. p. 365–75.
Boyle DB. Disease and fertility control in wildlife and feral animal populations: options for vaccine delivery using vectors. Reprod Fertil Dev. 1994;6:393–400.
Wu X, Franka R, Svoboda P, et al. Development of combined vaccines for rabies and immunocontraception. Vaccine. 2009;27:7202–9.
CDC. CDC health information for international travel 2012. New York: Oxford University Press; 2012.
Kuzmin IV, Tordo N. Genus Lyssavirus. In: Dietzgen RG, Kuzmin IV, editors. Rhabdoviruses, molecular taxonomy, evolution, genomics, ecology, host-vector Interactions, cytopathology and control. Norfolk: Caister Academic Press; 2012. p. 37–57.
Acknowledgments
The authors would like to thank Jesse D. Blanton and Jessie L. Dyer for their assistance in the preparation of this manuscript.
Disclaimer
The findings and conclusions in this chapter are those of the authors and do not necessarily represent the view of the Centers for Disease Control and Prevention.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Christian, K.A., Rupprecht, C.E. (2014). Rhabdovirus: Rabies. In: Kaslow, R., Stanberry, L., Le Duc, J. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7448-8_28
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7448-8_28
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7447-1
Online ISBN: 978-1-4899-7448-8
eBook Packages: MedicineMedicine (R0)